AST 081
Alternative Names: AST-081Latest Information Update: 17 Sep 2021
Price :
$50 *
At a glance
- Originator Pinotbio
- Class Antineoplastics
- Mechanism of Action DNA cytosine 5 methyltransferase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Acute myeloid leukaemia
Most Recent Events
- 24 Aug 2021 Preclinical trials in Acute myeloid leukaemia in South Korea (unspecified route) (Aston Science company pipeline, August 2021)
- 24 Aug 2021 Aston Science completes IND-enabling studies for AST 081 for the treatment of Acute myeloid leukaemia prior to August 2021 (Aston Science company pipeline, August 2021)